Anti-CD14 antibody [MEM-15] (FITC) (ab28061)

Publishing research using ab28061? Please let us know so that we can cite the reference in this datasheet.

ab28061 has been referenced in 3 publications.

  • Gonda K  et al. Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer. Oncol Lett 14:1766-1774 (2017). PubMed: 28789407
  • Steensma MR  et al. Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy. PLoS One 8:e69101 (2013). Flow Cyt ; Human . PubMed: 23922683
  • Sing A  et al. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J Exp Med 196:1017-24 (2002). PubMed: 12391013

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up